Startups
Neo Kuma Ventures invests in early stage psychedelic healthcare companies at the forefront of clinical research into illnesses including depression, PTSD, addiction, inflammation and chronic pain. By working with the leading companies in this field we will advance and redefine the standard of patient care.
Our fund invests in pre-seed to series A, where we can play a valuable role as investors.
For more information please email [email protected]
Our fund invests in pre-seed to series A, where we can play a valuable role as investors.
For more information please email [email protected]
Overview
Location
United Kingdom, England, London
Employees
1-10
Founded date
2020
Mentions in press and media 6
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| May 4, 2022 | Psychedelics startups are on a long journey to consumer markets, but these 5 VCs are taking the ride | “Like a pressure cooker, COVID blew the lid off what was a simmering mental health crisis for over a decade,” VC Tim Schlidt told TechCrunch. According to the World Health Organization, the global prevalence of anxiety and depression increa... |
| Nov 4, 2021 | Fluence Raises Investment to Meet Demand for Psychedelic Therapy Training | We look forward to implementing the expansion that this funding will allow and welcoming the next generation of therapists to our field. WOODSTOCK, N.Y. (PRWEB) November 04, 2021 Today, psychedelic therapy training provider Fluence announce... |
| Nov 2, 2021 | Wavepaths Raises $4.5 Million to Expand Experiential Music Platform for Psychedelic Therapy | With Wavepaths, I can actively curate a journey that will resonate with client emotions and encourage transformative experiences even after leaving my office. LONDON (PRWEB) November 02, 2021 Wavepaths, the world's leading producer of music... |
| Jun 3, 2021 | Psychedelic healthcare fund Neo Kuma sees early success amid sector growth | The UK’s first investment fund dedicated solely to psychedelic healthcare, Neo Kuma is reporting that a number of its early investments are returning yields between 180% and 680%, with three of the seven companies in its portfolio planning ... |
| Psychedelic healthcare fund Neo Kuma sees early success amid sector growth | The UK’s first investment fund dedicated solely to psychedelic healthcare, Neo Kuma is reporting that a number of its early investments are returning yields between 180% and 680%, with three of the seven companies in its portfolio planning ... |
Reviews 0
FAQ about Neo Kuma Ventures
When was Neo Kuma Ventures founded?
Neo Kuma Ventures was founded in 2020.
What has the press written about Neo Kuma Ventures?
Parsers VC has collected 6 articles mentioning Neo Kuma Ventures, among them “Psychedelics startups are on a long journey to consumer markets, but these 5 VCs are taking the ride” (May 4, 2022) and “Fluence Raises Investment to Meet Demand for Psychedelic Therapy Training” (Nov 4, 2021).
Is Neo Kuma Ventures still active?
Yes, Neo Kuma Ventures is active; its latest activity on Parsers VC dates from May 12, 2023.